Svb Leerink Weighs in on Agilent Technologies Inc’s FY2019 Earnings (NYSE:A)

Agilent Technologies Inc (NYSE:A) – Investment analysts at Svb Leerink raised their FY2019 EPS estimates for Agilent Technologies in a report issued on Wednesday, August 14th. Svb Leerink analyst P. Souda now anticipates that the medical research company will post earnings of $3.08 per share for the year, up from their previous forecast of $3.04. Svb Leerink also issued estimates for Agilent Technologies’ Q1 2020 earnings at $0.83 EPS, Q2 2020 earnings at $0.79 EPS, Q3 2020 earnings at $0.85 EPS, Q4 2020 earnings at $0.95 EPS, FY2020 earnings at $3.42 EPS and FY2021 earnings at $3.79 EPS.

A number of other equities research analysts have also recently weighed in on the company. Piper Jaffray Companies upped their price target on Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a report on Thursday, August 15th. Deutsche Bank lowered their target price on Agilent Technologies from $90.00 to $85.00 and set a “buy” rating on the stock in a report on Wednesday, May 15th. Bank of America cut Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 target price on the stock. in a report on Tuesday, July 16th. Barclays cut Agilent Technologies from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $86.00 to $78.00 in a report on Monday, July 15th. Finally, Robert W. Baird reiterated an “outperform” rating and set a $82.00 target price (up previously from $79.00) on shares of Agilent Technologies in a report on Thursday, August 15th. Six equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $84.77.

A opened at $71.12 on Monday. The stock has a market cap of $22.46 billion, a P/E ratio of 25.49, a P/E/G ratio of 1.96 and a beta of 1.41. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.13 and a quick ratio of 1.72. The stock’s 50 day simple moving average is $70.51 and its 200 day simple moving average is $74.54. Agilent Technologies has a 1-year low of $61.01 and a 1-year high of $82.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 14th. The medical research company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. The business had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Agilent Technologies had a return on equity of 20.00% and a net margin of 21.06%. The company’s revenue was up 5.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.67 EPS.

Several hedge funds have recently bought and sold shares of A. Dimensional Fund Advisors LP boosted its holdings in shares of Agilent Technologies by 4.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,031,349 shares of the medical research company’s stock worth $69,567,000 after purchasing an additional 47,062 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Agilent Technologies by 7.2% during the fourth quarter. Geode Capital Management LLC now owns 4,234,035 shares of the medical research company’s stock worth $285,139,000 after purchasing an additional 285,330 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Agilent Technologies during the first quarter worth $319,000. Strs Ohio boosted its holdings in shares of Agilent Technologies by 30.2% during the first quarter. Strs Ohio now owns 21,295 shares of the medical research company’s stock worth $1,711,000 after purchasing an additional 4,934 shares during the last quarter. Finally, Financial Gravity Wealth Inc. acquired a new stake in shares of Agilent Technologies during the first quarter worth $52,000.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: Why do corrections happen?

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.